<DOC>
	<DOCNO>NCT01765530</DOCNO>
	<brief_summary>The purpose study evaluate in-vivo efficacy novel device ( endOclear ) clean endotracheal tube ( ETT ) lumen secretion . The investigator hypothesize protocol routine ETT cleaning endOclear may increase ETT luminal volume measure extubation compare current standard care . The device may therefore clinically useful well maintain ETT original function .</brief_summary>
	<brief_title>Efficacy Study Novel Device Clean Endotracheal Tube</brief_title>
	<detailed_description>After day mechanical ventilation ( MV ) , lumen endotracheal tube ( ETT ) coat thick bacterial biofilm , potential source bacterial colonization lower respiratory tract ventilator-associated pneumonia ( VAP ) . Accumulation mucus/secretions interior ETT also effectively lower cross section ETT increase significantly work breathing intubated patient , require increase MV support , prolong intubation ICU stay . A primary goal ICUs shorten time MV , decrease incidence ETT microbial colonization ultimately VAP incidence . To meet goal several airway technology maintain ETT free debris/bacteria develop order improve current ventilator-liberation standard intubate critically ill patient . Based preliminary laboratory , animal clinical data , The investigator wish test hypothesis novel commercially available ETT cleaning device effective target two specific issue : - Specific aim 1 : To evaluate mean difference ETT luminal volume ETTs clean novel cleaning device ( EndOclear ) vs. ETT clean standard manner . - Specific aim 2 : To determine whether ETTs clean novel device show lower degree microbial colonization entire period mechanical ventilation . Data in-vivo respiratory mechanic measurement , microbial diversity antibiotic resistance analysis , user ' feedback safety device also collect . The investigator conduct clinical trial 74 intubated patient randomize receive standard ETT cleaning clean EndOclear .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Airway Obstruction</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<criteria>Age â‰¥ 18 year Patients expect intubated least 48 hour longer Enrollment within 24 hour intubation time Current past participation another intervention trial conflict present study Pregnant woman prisoner</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Medical Devices</keyword>
	<keyword>Ventilator-Associated Pneumonia ( VAP )</keyword>
	<keyword>Ventilator-Associated Events ( VAE )</keyword>
	<keyword>Endotracheal Tube</keyword>
	<keyword>Microbial Diversity</keyword>
	<keyword>Anti-Resistance</keyword>
	<keyword>Computed Tomography ( CT )</keyword>
</DOC>